ACCUiN BioTech Inc.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Providing comprehensive genetic testing solutions, from reagent kits to automated analysis software, to meet a wide range of clinical and research needs. These include next-generation genetic testing, disease risk genetic testing, newborn/pre-pregnancy genetic screening, pathogen infection detection, and laboratory setup services.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
91018042
Status
Active
Number of Employees
0
Total Paid-in
Capital
29,100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ACCUiN Biotech was established in 2021, focusing on the fields of genomics, oncology, and infectious diseases, and is committed to developing high-quality detection kits and automated analysis software. Relying on a professional team and continuous technological innovation, ACCUiN Biotech has rapidly become one of the leaders in this field.
Based on years of technical accumulation and development experience, our products are in an industry-leading position in key indicators such as accuracy, sensitivity, and stability. The products are widely used in fields such as cancer genomics, hereditary diseases, disease risk, and pathogen detection.
Based on years of technical accumulation and development experience, our products are in an industry-leading position in key indicators such as accuracy, sensitivity, and stability. The products are widely used in fields such as cancer genomics, hereditary diseases, disease risk, and pathogen detection.
The content above was translated by Ai
